UKRLIV SUSPENSION
PHARMACEUTICAL FORM:
Oral suspension
Active substance:
Ursodeoxycholic acid
Composition:
Each 5 ml of suspension contains 250 mg of ursodeoxycholic acid
Indications for use:
Symptomatic treatment of primary biliary cirrhosis (PBC). Dissolution of X-ray-negative cholesterol gallstones up to 15 mm in diameter. Treatment of hepatobiliary disorders in cystic fibrosis in children aged 1 month to 18 years old.
